Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer

Bing Guan(First Affiliated Hospital of Xi'an Jiaotong University), Yuefeng Du(First Affiliated Hospital of Xi'an Jiaotong University)

Oncotarget

December 24, 2016

10.18632/oncotarget.14131

Cited by 61

Related Papers

Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling

|International Journal of Oncology|2015|122

MicroRNA‑218 inhibits the migration, epithelial‑mesenchymal transition and cancer stem cell properties of prostate cancer cells

|Oncology Letters|2018|25

Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer

|Oncology Reports|2015|14